Product Data Sheet

(Rac)-EP-2825

Catalog No. A61590

main product photo
(Rac)-EP-2825 is a MRGPRD agonist exhibiting an IC50 value between 100 and 500 nM. It plays a significant role in pain research, providing insights into the mechanisms of nociception and potential therapeutic interventions. This compound facilitates the exploration of MRGPRD pathways, contributing to a better understanding of pain modulation and associated biological processes.
Chemical Information
Catalog NumA61590
M. Wt428.95
FormulaC23H29ClN4O2
Purity>98%
Storageat -20 °C 3 years (powder form); at -20 °C 6 months (Solution base)
CAS No.958571-34-1
Synonyms
SMILESO=C1N=C(NC2CCN(CC2)C(C(C)(C)C3=CC=C(C=C3)Cl)=O)NC4=C1CCCC4
Biological Activity
Description(Rac)-EP-2825 is a MRGPRD agonist exhibiting an IC50 value between 100 and 500 nM. It plays a significant role in pain research, providing insights into the mechanisms of nociception and potential therapeutic interventions. This compound facilitates the exploration of MRGPRD pathways, contributing to a better understanding of pain modulation and associated biological processes.
RETURN POLICY
Adooq’s Unconditional Return Policy ensures a smooth online shopping experience for our customers. If you are in any way unsatisfied with your purchase, you may return any item(s) within 7 days of receiving it. In the event of product quality issues, either protocol related or product related problems, you may return any item(s) within 365 days from the original purchase date. Please follow the instructions below when returning products.
SHIPPING AND STORAGE
Adooq products are transported at room temperature. If you receive the product at room temperature, please rest assured, the Adooq Quality Inspection Department has conducted experiments to verify that the normal temperature placement of one month will not affect the biological activity of powder products. After collecting, please store the product according to the requirements described in the datasheet. Most Adooq products are stable under the recommended conditions.